[{"id":"ff97280b-5158-4cfd-9c5a-f26687042df7","acronym":"","url":"https://clinicaltrials.gov/study/NCT01591356","created_at":"2021-01-18T06:47:41.602Z","updated_at":"2024-07-02T16:35:14.295Z","phase":"Phase 1","brief_title":"EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors","source_id_and_acronym":"NCT01591356","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" EPHA2","pipe":" | ","alterations":" EPHA2 overexpression","tags":["EPHA2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EPHA2 overexpression"],"overall_status":"Recruiting","enrollment":" Enrollment 76","initiation":"Initiation: 07/01/2015","start_date":" 07/01/2015","primary_txt":" Primary completion: 04/30/2025","primary_completion_date":" 04/30/2025","study_txt":" Completion: 04/30/2025","study_completion_date":" 04/30/2025","last_update_posted":"2024-03-18"}]